Gerry Brunk

Gerry Brunk is the Managing Director at Lumira Ventures, where the firm invests in life sciences companies to address significant unmet healthcare needs. Brunk serves on the Board of Directors for various medical and biotechnology companies, including SpectraWAVE, Inc., Endogenex, HistoSonics, Inc., Cadence Neuroscience Inc., enGene Inc., PIC Therapeutics, GenEp, and Cyrano Therapeutics, focusing on innovative treatments in areas such as coronary artery disease, diabetes, epilepsy, and cancer therapeutics. Additionally, Brunk is involved with Weston Drama Workshop, supporting youth through performing arts. Educational qualifications include an MBA from Stanford University Graduate School of Business and a BA in Biology and Economics from the University of Virginia.